Former Kadmon consultant pleads guilty to insider trading ahead of Sanofi buyout

While Sanofi scooped up an FDA-approved drug in its purchase of Kadmon Holdings, a consultant to the latter company landed himself a charge for insider trading around the deal. Now, he's pled guilty.